Editorial Note

I am pleased to introduce Pharmaceutical Biotechnology: Current Research which is a multidisciplinary peer reviewed journal that provides insight into the process of biopharmaceutical drug discovery and its impact on the practice of medicine. The journal focuses on the wide spread dispersal of recent developments in biotechnological tools and techniques and evolution of novel pharmaceutical drugs. Pharmaceutical biotechnological research includes studies on the application of recombinant DNA technology, microbiology, genomics, proteomics and industrial biotechnology. We have been started in year 2008 International Journal of Pharmaceutical Biotechnology is growing continuously. It is our pleasure to announce that during year 2019, all issues published online on time and the print issues were also brought out and dispatched within 30 days of publishing the issue online.

 

All published articles of this journal are included in the indexing and abstracting coverage of CAS Source Index (CASSI), Index Copernicus, Google Scholar, Sherpa Romeo, Academic Journals Database, Genamics Journal Seek, Journal TOCs, Cite Factor, Electronic Journals Library, RefSeek, Hamdard University, EBSCO A-Z, Directory of Abstract Indexing for Journals, World Catalogue of Scientific Journals, OCLC- WorldCat, Scholarsteer, SWB online catalog, Virtual Library of Biology (vifabio), Publons, Dtufindit, Geneva Foundation for Medical Education and Research.

 

During the calendar year 2019, Pharmaceutical Biotechnology: Current Research received a total of 30 papers, out of which 6 articles were rejected in the preliminary screening due to plagiarism or being out of the format and peer review process. During 2019 around 9 articles were subjected for publication after they are accepted in the peer review process. In the 3 issues of Volume 3 published during the year 2019, a total of 9 articles were published (at an average of 3 articles per issue of which, articles were published from authors all around the world. A total of 30 research scientists from all over the world reviewed the 9 articles published in volume 3. Average publication period of an article was further reduced to 14-21 days.

 

During the calendar year 2019, a total of three Editors, ten Reviewers joined the board of PBCR and contributed their valuable services towards contribution as well as publication of articles, and their valuable reviewer comments will beneficial to publish quality of article in the Journal.

 

I take this opportunity to acknowledge the contribution of Editor-in-chief and Associate Editor during the final editing of articles published and bringing out issues of PBCR in time. I would also like to express my gratitude to all the authors, reviewers, the publisher, language editor, honorary editors, the scientific advisory and the editorial board of PBCR, the office bearers for their support in bringing out the new volume (Volume 4) of PBCR for the calendar year 2020 and look forward to their unrelenting support further to release more issues for Pharmaceutical Biotechnology: Current Research (PBCR) in scheduled time.

Author(s): Sarmistha M

Abstract | PDF

Share This Article